Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRVT PLACEMENT PRICED: Cheplapharm €390m 7NC3 Snr Sec 8% at 100

HYC European Market: Deal Flow - General

Issuer

Term

Call

Coupon

Maturity

Size

Ranking

Type

Price

Yield

Spread

Cheplapharm Arzneimittel GmbH

7NC3

3

8%

30-Oct-33

€390m

Snr Sec

Fixed

100

8%

B+477


Reoffer: 7NC3: B+477bp / 100 / 8%
Benchmark: 7NC3: DBR 2.6 15-Aug-33 / B+477bp


  • Company: Cheplapharm
  • Issuer: Cheplapharm Arzneimittel GmbH
  • Ticker: CHEPDE
  • Business: Leading global specialty pharmaceutical platform that manages a highly diversified portfolio of well-established, branded legacy and niche originator products which are typically off-patent and benefit from resilient, long-term demand
  • HQ: Greifswald, Germany
  • UoP: Fund the Project Latour cash purchase price payment
  • Facility: Privately Placed € SSN
  • Size: €390m
  • Ranking: Senior Secured Notes
  • Call Protection: NC3
  • Maturity: 30-Oct-33
  • ISIN (Reg S): XS3539366115
  • Corporate Ratings (Moody's/S&P/Fitch): B2 (Positive) / B (CreditWatch Positive) / B (CreditWatch Positive)
  • Instrument Ratings (Moody's/S&P/Fitch): B2/B/B+
  • Rating Split: Issuer: B2 (Positive)/B (CreditWatch Positive)/B (CreditWatch Positive) (Moody's/S&P/Fitch), Issue: B2/B/B+ (Moody's/S&P/Fitch)
  • Lead Placement Agent: UBS
  • Placement Agents: Deutsche Bank, JP Morgan
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.